
Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times
Author(s) -
Howard W. Bruckner,
Fred Bassali,
Elisheva Dusowitz,
Daniel Gurell,
Abe Book,
Robert De Jager
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0276492
Subject(s) - medicine , cetuximab , gastroenterology , irinotecan , colorectal cancer , bevacizumab , progression free survival , oncology , docetaxel , cancer , chemotherapy